By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Vivani Medical, Inc.

Vivani Medical, Inc. (VANI)

NASDAQ Currency in USD
$442.00
+$1.49
+0.34%
Last Update: 18 Jul 2026, 14:26
$27.58bn
Market Cap
-1.11k
P/E Ratio (TTM)
Forward Dividend Yield
$325.33-$611.10
52 Week Range

VANI Stock Price Chart

Explore Vivani Medical, Inc. interactive price chart. Choose custom timeframes to analyze VANI price movements and trends.

VANI Company Profile

Discover essential business fundamentals and corporate details for Vivani Medical, Inc. (VANI) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

19 Nov 2014

Employees

37.00

CEO

Adam Mendelsohn

Description

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.

VANI Financial Timeline

Browse a chronological timeline of Vivani Medical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 Aug 2026

EPS estimate is -$0.08.

Earnings released on 13 May 2026

EPS came in at -$0.08 matching the estimated -$0.08.

Earnings released on 26 Mar 2026

EPS came in at -$0.09 matching the estimated -$0.09.

Earnings released on 13 Nov 2025

EPS came in at -$0.11 surpassing the estimated -$0.12 by +8.33%.

Earnings released on 13 Aug 2025

EPS came in at -$0.12 falling short of the estimated -$0.10 by -20.00%.

Earnings released on 13 May 2025

EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%.

Earnings released on 31 Mar 2025

EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%, while revenue for the quarter reached $398.00k .

Earnings released on 13 Nov 2024

EPS came in at -$0.11 matching the estimated -$0.11.

Earnings released on 13 Aug 2024

EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%.

Earnings released on 13 May 2024

EPS came in at -$0.12 matching the estimated -$0.12.

Earnings released on 26 Mar 2024

EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%, while revenue for the quarter reached $518.00k .

Earnings released on 14 Nov 2023

EPS came in at -$0.13 matching the estimated -$0.13.

Earnings released on 14 Aug 2023

EPS came in at -$0.13 falling short of the estimated -$0.11 by -18.18%.

Earnings released on 15 May 2023

EPS came in at -$0.12 falling short of the estimated -$0.11 by -9.09%.

Earnings released on 31 Mar 2023

EPS came in at -$0.18 .

Earnings released on 14 Nov 2022

EPS came in at $0.04 .

Stock split effective on 19 Aug 2022

Shares were split 1 : 3 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 11 Aug 2022

EPS came in at -$0.08 .

Earnings released on 4 Jul 2022

EPS came in at -$0.12 .

Earnings released on 28 Mar 2022

EPS came in at -$0.09 , while revenue for the quarter reached $260.00 , beating expectations by +8.33%.

Earnings released on 12 Nov 2021

EPS came in at -$0.11 .

Earnings released on 30 Sept 2021

EPS came in at -$0.08 .

VANI Stock Performance

Access detailed VANI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run